Cardiocommand Inc.: Medical Device Recalls in 2019

Updated on March 25, 2026.

According to to data from the FDA, there were 2 medical device recalls made by Cardiocommand Inc. in 2019. See the details of the recalls below.

You can see similar recalls for other firms.

Data Source: FDA.

See this for other years:

TAPSYSTEM Model 2A, REF 8002A
CardioCommand, Inc. Transesophageal Cardiac Pacing and Recording System, Model 7A, REF 0101 - Product Usage: Indications for Use: - Temporary left atrial pacing to treat bradycardia, hypotension or AV junctional rhythm - Acceleration of heart rate as an alternative to exercise or drugs during diagnostic cardiac studies such as echocardiography or radionuclide ventriculography. - Antitachycardia pacing for cardioversion of supraventricular tachycardia (SVT), including atrial flutter and re-entrant atrial or atrioventricular paroxysmal tachycardia. - Esophageal electrocardiography for differential diagnosis of complex atrial arrhythmia